Press Release

Hand, Foot, and Mouth Disease Treatment Market to be dominated by Growing Prevalence of Viral Infections through 2027

Growing incidence of viral infections and rising research and development activities to drive the hand, foot, and mouth disease treatment market in the forecast period, 2023-2027.

According to TechSci Research report, “Hand, Foot, and Mouth Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027, the global hand, foot, and mouth disease treatment is anticipated to grow at a significant rate in the forecast period, 2023-2027. The increase in incidences of viral infections, and extensive research and development are the primary factors driving the growth of the market. Growing government investments on R&D activities, growing footprint of pharmaceutical manufacturers, developed healthcare infrastructure, and rising awareness among the masses, are expected to influence the market demand. Also, the ease in FDA approvals for HFMD drugs in clinical trial phase is also a key factor for increasing the growth of the market, globally.

However, the risk of developing other diseases such as Reye syndrome on consumption of pain relief drugs such as Aspirin may likely hamper the growth of the market.in the forecast period.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Hand, Foot, and Mouth Disease Treatment Market"

 

The global hand, foot, and mouth disease treatment is segmented into drug type, route of administration, distribution channel, and company.

Based on drug type, the market is divided into pain relievers, non-steroidal anti-inflammatory drugs, and nucleoside analogue antivirals. The pain relievers segment is slated to proliferate during the forecast period due to the easily availability and cost-effective of these drugs.

Based on route of administration, the market is divided into topical, oral, and intravenous. The oral segment is expected to witness largest market share as it is the most convenient route. Also, patient preference, and ease of large-scale manufacturing of oral dosage forms are other reasons curbing the segment growth.

Based on application, the market is segmented into drug discovery & development, diagnostics, agriculture & animal research, and others. The drug discovery & development segment is anticipated to grow during the forecast period. This is attributed to the growing research on diseases such as cancer, chronic diseases, genetic disorders, and the reducing cost of sequencing.  

Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The online pharmacies segment is anticipated to grow during the forecast period as they are convenient and patient privacy.

Major operating companies operating in global hand, foot, and mouth disease treatment are:

  • Johnson & Johnson
  • GlaxoSmithKline plc.
  • Emergex Vaccines Holdings Ltd
  • Takeda Pharmaceutical Co Ltd
  • CJ HealthCare Corp.
  • Adimmune Corp


Download Free Sample Report

Customers can also request for 10% free customization on this report.

“Asia-Pacific region dominates the market in 2021 and is expected to maintain its dominance in the coming years due to the rising occurrences of HFMD in children. Also, the early approval of drugs, rising awareness programs for HFMD and increasing funding for clinical trials, well-established healthcare infrastructure, and hub for new market players in the region are expected to propel the global hand, foot, and mouth disease treatment growth till 2027” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

Hand, Foot, and Mouth Disease Treatment - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals), By Route of Administration (Topical, Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Company, and By Region”, has evaluated the future growth potential of global hand, foot, and mouth disease treatment and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global hand, foot, and mouth disease treatment market.


Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com

Relevant News